TD-198946
Product Specifications
UNSPSC Description
TD-198946, a thienoindazole derivative, is a potent chondrogenic agent.
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/TD-198946.html
Solubility
DMSO : ≥ 28 mg/mL
Smiles
O=C(C1=C2CCC3=C(N(C)N=C3)C2=C(OC4=CC=C(OCC5=NC6=CC=CC=C6C=C5)C=C4)S1)N
Molecular Weight
482.55
References & Citations
[1]Yano F, et al. A novel disease-modifying osteoarthritis drug candidate targeting Runx1. Ann Rheum Dis. 2013 May;72(5):748-53.|[2]Yano F, et al. Disease-modifying effects of TD-198946 on progressed osteoarthritis in a mouse model. Ann Rheum Dis. 2014 Nov;73(11):2062-4.|[3]Yano F, et al. Cell-sheet technology combined with a thienoindazole derivative small compound TD-198946 for cartilage regeneration. Biomaterials. 2013 Jul;34(22):5581-7.|[4]Kobayashi M, Chijimatsu R, Hart DA, et al. Evidence that TD-198946 enhances the chondrogenic potential of human synovium-derived stem cells through the NOTCH3 signaling pathway. J Tissue Eng Regen Med. 2021;15(2):103-115.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-15642/TD-198946-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-15642/TD-198946-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
364762-86-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Monoclonal CD45RA Antibody (PTPRC/8341R) [DyLight 550]](https://cdn.genprice.uk/genprice/genprice2.png)
MBS6174020-01 0.1 mL
MUC1 (Mucin 1, Cell Surface Associated, CD227, EMA, H23AG, MAM6, PEM, PEMT, PUM) (Biotin)
Ask
View Details 
MBS6174020-02 5x 0.1 mL
MUC1 (Mucin 1, Cell Surface Associated, CD227, EMA, H23AG, MAM6, PEM, PEMT, PUM) (Biotin)
Ask
View Details